University Health Network, Toronto
1,634
263
377
823
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
148 terminated/withdrawn out of 1634 trials
84.8%
-1.8% vs industry average
11%
177 trials in Phase 3/4
8%
67 of 823 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1634)
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Role: collaborator
Erector Spinae Plane (ESP) Block Volunteer Study
Role: lead
Shoulder RA Survey Study
Role: lead
AI for Gastric POCUS ( Point-of-care Ultrasound)
Role: lead
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Role: collaborator
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
Role: lead
Levetiracetam for Persons at Risk for Alzheimer's Disease
Role: collaborator
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
Role: lead
PRT for Chronic Low Back Pain
Role: lead
Finding the Optimal Resistance Training Intensity For Your Bones
Role: collaborator
Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients
Role: lead
Improving Pain Disability With the Use of Oral Cannabinoids
Role: lead
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Role: lead
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Role: lead
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Role: lead
Oculomotor Rehabilitation After Concussion in Adults: A Feasibility Study
Role: lead
Cannabinoids for Osteoarthritis Pain Effectiveness Trial
Role: lead
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
Role: lead
Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies
Role: lead
Integrated Molecular Profiling in Advanced Cancers Trial
Role: lead